Literature DB >> 20113904

Update on thalassemia: clinical care and complications.

Melody J Cunningham1.   

Abstract

beta-Thalassemia, originally named Cooley anemia, is an inherited blood disease. Various types of thalassemia are inherited anemias caused by mutations at the globin gene loci on chromosomes 16 and 11, affecting the production of alpha- or beta-globin protein, respectively. The combination of early diagnosis, improvements in monitoring for organ complications, and advances in supportive care have enabled many patients who have severe thalassemia syndromes to live productive, active lives well into adulthood. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20113904     DOI: 10.1016/j.hoc.2009.11.006

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  6 in total

1.  Providers' Perspectives on Treating Patients With Thalassemia.

Authors:  Taylor Radke; Susan Paulukonis; Mary M Hulihan; Lisa Feuchtbaum
Journal:  J Pediatr Hematol Oncol       Date:  2019-10       Impact factor: 1.289

2.  Marital Status and Fertility in Adult Iranian Patients with β-Thalassemia Major.

Authors:  Ghasem Miri-Aliabad; Mahsoumeh Fadaee; Ali Khajeh; Majid Naderi
Journal:  Indian J Hematol Blood Transfus       Date:  2015-02-07       Impact factor: 0.900

3.  Epidemiologic Trends of Thalassemia, 2006-2018: A Nationwide Population-Based Study.

Authors:  Jee-Soo Lee; Tae-Min Rhee; Kibum Jeon; Yonggeun Cho; Seung-Woo Lee; Kyung-Do Han; Moon-Woo Seong; Sung-Sup Park; Young Kyung Lee
Journal:  J Clin Med       Date:  2022-04-20       Impact factor: 4.964

4.  Study of alloimmunization and autoimmunization in Iranian β-thalassemia major patients.

Authors:  Kambiz Davari; Mohammad Soleiman Soltanpour
Journal:  Asian J Transfus Sci       Date:  2016 Jan-Jun

5.  Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior.

Authors:  Shahla Ansari; Azita Azarkeivan; Ghasem Miri-Aliabad; Saeed Yousefian; Tahereh Rostami
Journal:  Caspian J Intern Med       Date:  2017

6.  Clinical characteristics of pediatric thalassemia in Korea: a single institute experience.

Authors:  Che Ry Hong; Hyoung Jin Kang; Ji Won Lee; Hyery Kim; Nam Hee Kim; Kyung Duk Park; June Dong Park; Moon-Woo Seong; Sung Sup Park; Hee Young Shin; Hyo Seop Ahn
Journal:  J Korean Med Sci       Date:  2013-10-31       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.